Vilya-1 Improves Macrocycle Conformation Prediction
DaveJuergens · x · 2026-07-18
Vilya-1 is an all-atom diffusion-based foundation model designed for macrocycle conformation prediction and design. It aims to solve a core bottleneck in drug discovery: stably sampling biologically relevant, low-energy conformations across diverse synthesizable chemical spaces, moving beyond standard peptides.
The authors report that across 66 cyclic peptide X-ray structures, Vilya-1 achieved an 89.2% success rate in generating near-native ring conformations (ring RMSD < 1 Å), significantly outperforming Prime-MCS, RDKit ETKDGv3, Boltz-2/RF3, and several deep learning conformational generators.
The model also generalizes across various macrocycle types and topologies, including:
- Disulfide-linked cyclic peptides
- Sidechain-to-sidechain cyclization
- Tail-to-sidechain cyclization
- Non-peptidic macrocycles, such as macrolides/polyketides
The post also mentions FK506 among the example molecules.
More from Research
- Artificial Analysis chart compares Gemini 3.5 Flash-Lite with 3.6 Flash — Expensive_Syrup_6529 · 2026-07-21
- Gritt raises a new round to automate solar array installation and maintenance — rebeccakaden · 2026-07-21
- NSA's Mike O'Hara: AI Puts Math Research Progress on 'Fruit Fly Years' — AlexKontorovich · 2026-07-21
- Cell study: localized PD-1 engineered T cells reduce brain inflammation in mice — EricTopol · 2026-07-21
- Linear Digressions returns with a new season of audio essays on AI agents — ChrisGPotts · 2026-07-21
- A forecasting lesson on why R-squared alone led to overfitting and worse predictions — mdancho84 · 2026-07-21